Plant Comparison
Turmeric vs Oyster mushroom
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Turmeric and Oyster mushroom: they share 7 indicated uses (arthritis / joint pain, blood sugar / diabetes support, cancer (anticancer research), …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Turmeric | Oyster mushroom | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 3/10 | 5/10 | Stronger for Oyster mushroom |
| Blood sugar / diabetes support | 3/10 | 6/10 | Stronger for Oyster mushroom |
| Cancer (anticancer research) | 1/10 | 8/10 | Stronger for Oyster mushroom |
| Cardiovascular / heart health | 3/10 | 6/10 | Stronger for Oyster mushroom |
| Inflammation (general) | 3/10 | 5/10 | Stronger for Oyster mushroom |
| Metabolic support | 3/10 | 6/10 | Stronger for Oyster mushroom |
| Skin irritation | 3/10 | 5/10 | Stronger for Oyster mushroom |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The principal yellow-orange pigments and best-studied bioactive compounds, responsible for most of turmeric's anti-inflammatory and antioxidant activity; oral bioavailability is low unless combined with piperine or a lipid carrier.
Aromatic sesquiterpenes (including turmerone) contributing to fragrance and additional bioactivity.
The principal bioactive constituents, responsible for most of the mushroom's immunomodulatory and anticancer activity.
Contribute to immunomodulatory activity alongside the pure beta-glucans.
Contribute to the antioxidant activity of the fruiting body.
Pharmacological Actions
Traditional & Indicated Uses
inferred from gastroprotective action
inferred from antidiabetic action
inferred from anticancer action
inferred from gastroprotective action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Generally very safe in culinary quantities. High-dose curcumin supplements may cause gastrointestinal upset. May interact with anticoagulants (warfarin), antidiabetic drugs, and acid-suppressing medications. Avoid very high doses during pregnancy and breastfeeding. Rarely causes allergic reactions.
Duke (2002) rates turmeric as +++ with clinical evidence (score 2) for anti-inflammatory activity, consistent with Commission E and WHO approvals. Curcumin is the primary bioactive compound with well-documented anti-inflammatory, antioxidant, anti-aggregant, and hepatoprotective effects. Duke notes Commission E approval for dyspeptic complaints. Dose: 1.5–3 g dried rhizome powder daily. A major pharmacological consideration is bioavailability: curcumin alone has low absorption, but combining with piperine (black pepper) increases bioavailability by up to 2000%. Contraindicated in bile duct obstruction; use with caution in gallstones and during pregnancy at medicinal doses (Duke, 2002).
Generally very safe as a food. Rare cases of occupational asthma and allergy reported among people working with mushroom cultivation. Safe for culinary use without significant known interactions.
External Ids
Botanical Description
Rhizomatous perennial herb with large, broad, lance-shaped leaves arising directly from the underground rhizome in a clump. Pale yellow flowers are borne in a dense spike partly hidden among pale green to pink upper bracts. The branching, knobbly rhizome has a bright orange-yellow interior, the source of turmeric spice and dye.[1]
Wood-decay fungus (not a true plant, Pleurotaceae) that grows in shelf-like, overlapping clusters on dead or dying hardwood trees and stumps. Fan- or oyster-shell-shaped caps, 5-25 cm across, are usually grey, tan or brown (occasionally pale or white), with white gills running down a short, off-centre stem. The mycelium is a fine white network that colonises and decomposes the wood substrate before fruiting.
Habitat
Native to South Asia (India) and Southeast Asia; cultivated extensively in warm, humid tropical climates on well-drained, fertile soils.
Grows naturally on dead or dying broadleaf (hardwood) trees - beech, oak, poplar and others - in temperate forests worldwide; widely cultivated commercially on straw, sawdust and other lignocellulosic substrates.
Harvesting
The rhizomes are dug at the end of the growing season, typically 8-10 months after planting, when the leaves have died back; they are cleaned, boiled or steamed, then dried and often ground into the familiar yellow powder.
Wild fruiting bodies are picked as the caps mature but before they become tough or insect-damaged; cultivated mushrooms are harvested from substrate blocks or bags once the caps have expanded but before releasing significant spore load. Never forage a white shelf-fungus from wood without confirming the host tree, since the fatal Angel Wing look-alike is specific to conifer (softwood) wood.[14]
Traditional Uses
Turmeric rhizome is a cornerstone spice and medicine of Ayurvedic and traditional Chinese medicine, used for millennia as an anti-inflammatory, digestive and wound-healing remedy and valued as a golden dye; its curcuminoid-rich rhizome is now among the most extensively researched botanicals for inflammatory and joint conditions, directly building on this traditional reputation.[1, 13]
Oyster mushroom is a widely eaten culinary mushroom with a growing modern reputation as a medicinal fungus, valued for immune support and general wellbeing. Contemporary research on its beta-glucan polysaccharides supports immunomodulatory, antioxidant, anticancer and cardiometabolic activity.[1, 5]
Preparations
Rhizome extract standardised to curcuminoid content, often combined with piperine (black pepper extract) to improve absorption, taken as capsules; the form used in most clinical arthritis and inflammation studies.
Dosage
Clinical trials in arthritis commonly use around 1000-1500 mg of curcumin (or curcuminoid-standardised extract) daily, in divided doses, often combined with piperine. Educational reference only, not a prescription.
References
Drug Class Interactions
Not documented
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Zeng, L., Yang, T., Yang, K., Yu, G. et al (2022) 'Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Frontiers in Immunology, 13, pp. 891822. doi:10.3389/fimmu.2022.891822 Meta-analysis / review
https://doi.org/10.3389/fimmu.2022.891822 - Zeng, L., Yu, G., Hao, W., Yang, K. and Chen, H (2021) 'The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis', Bioscience Reports, 41(6), pp. BSR20210817. doi:10.1042/BSR20210817 Meta-analysis / review
https://doi.org/10.1042/BSR20210817 - Marton, L.T., Pescinini-E-Salzedas, L.M., Camargo, M.E.C., Barbalho, S.M. et al (2021) 'The Effects of Curcumin on Diabetes Mellitus: A Systematic Review', Frontiers in Endocrinology, 12, pp. 669448. doi:10.3389/fendo.2021.669448 Meta-analysis / review
https://doi.org/10.3389/fendo.2021.669448 - Kocaadam, B. and Sanlier, N (2017) 'Curcumin, an active component of turmeric (Curcuma longa), and its effects on health', Critical Reviews in Food Science and Nutrition, 57(13), pp. 2889-2895. doi:10.1080/10408398.2015.1077195 Meta-analysis / review
https://doi.org/10.1080/10408398.2015.1077195 - Vaughn, A.R., Branum, A. and Sivamani, R.K (2016) 'Effects of turmeric (Curcuma longa) on skin health: a systematic review of the clinical evidence', Phytotherapy Research, 30(8), pp. 1243-1264. doi:10.1002/ptr.5640 Meta-analysis / review
https://doi.org/10.1002/ptr.5640 - Soleimani, V., Sahebkar, A. and Hosseinzadeh, H (2018) 'Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: review', Phytotherapy Research, 32(6), pp. 985-995. doi:10.1002/ptr.6054 Meta-analysis / review
https://doi.org/10.1002/ptr.6054 - Zeng, L., Yang, T., Yang, K., Yu, G., Li, J., Xiang, W. and Chen, H (2022) 'Curcumin and Curcuma longa extract in the treatment of 10 types of autoimmune diseases: a systematic review and meta-analysis of 31 randomized controlled trials', Frontiers in Immunology, 13, pp. 896476. doi:10.3389/fimmu.2022.896476 Meta-analysis / review
https://doi.org/10.3389/fimmu.2022.896476 - Razavi, B.M., Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2021) 'A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents', Phytotherapy Research, 35(12), pp. 6489-6513. doi:10.1002/ptr.7224 Meta-analysis / review
https://doi.org/10.1002/ptr.7224 - Memarzia, A., Khazdair, M.R., Behrouz, S., Gholamnezhad, Z., Jafarnezhad, M., Saadat, S. and Boskabady, M.H (2021) 'Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review', BioFactors, 47(3), pp. 311-350. doi:10.1002/biof.1716 Meta-analysis / review
https://doi.org/10.1002/biof.1716 - Jurenka, J.S (2009) 'Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research', Alternative Medicine Review, 14(2), pp. 141-153. Meta-analysis / review
https://scholar.google.com/scholar?q=Anti-inflammatory%20properties%20of%20curcumin%2C%20a%20major%20constituent%20of%20Curcuma%20longa%3A%20a%20review%20of%20preclinical%20and%20clinical%20research - Hosseini, A. and Hosseinzadeh, H (2018) 'Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: a review', Biomedicine & Pharmacotherapy, 99, pp. 411-421. doi:10.1016/j.biopha.2018.01.072 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2018.01.072 - Araujo, C.C. and Leon, L.L (2001) 'Biological activities of Curcuma longa L', Memorias do Instituto Oswaldo Cruz, 96(5), pp. 723-728. doi:10.1590/s0074-02762001000500026 Meta-analysis / review
https://doi.org/10.1590/s0074-02762001000500026 - Aggarwal, B.B. and Harikumar, K.B (2009) 'Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases', 41(1), pp. 40--59. doi:10.1016/j.biocel.2008.06.010 Traditional / reference
https://doi.org/10.1016/j.biocel.2008.06.010 - Shoba, G. et al (1998) 'Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers', 64(4), pp. 353--356. doi:10.1055/s-2006-957450 Clinical study
https://doi.org/10.1055/s-2006-957450 - WHO (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Liu, A.C., Zhao, L.X. and Lou, H.X (2013) 'Curcumin alters the pharmacokinetics of warfarin and clopidogrel in Wistar rats but has no effect on anticoagulation or antiplatelet aggregation', Planta Medica, 79(11), pp. 971-977. doi:10.1055/s-0032-1328652 Preclinical
https://doi.org/10.1055/s-0032-1328652 - Tian, J., Feng, B. and Tian, Z (2022) 'The Effect of Curcumin on Lipid Profile and Glycemic Status of Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis', Evidence-Based Complementary and Alternative Medicine, 2022, pp. 8278744. doi:10.1155/2022/8278744 Meta-analysis / review
https://doi.org/10.1155/2022/8278744 - Willcox, M.L., Elugbaju, C., Al-Anbaki, M., Lown, M. and Graz, B (2021) 'Effectiveness of Medicinal Plants for Glycaemic Control in Type 2 Diabetes: An Overview of Meta-Analyses of Clinical Trials', Frontiers in Pharmacology, 12, pp. 777561. doi:10.3389/fphar.2021.777561 Meta-analysis / review
https://doi.org/10.3389/fphar.2021.777561 - Altobelli, E., Angeletti, P.M., Marziliano, C., Mastrodomenico, M., Giuliani, A.R. and Petrocelli, R (2021) 'Potential therapeutic effects of curcumin on glycemic and lipid profile in uncomplicated type 2 diabetes: a meta-analysis of randomized controlled trials', Nutrients, 13(2), pp. 404. doi:10.3390/nu13020404 Meta-analysis / review
https://doi.org/10.3390/nu13020404
- Motta, F., Gershwin, M.E. and Selmi, C (2021) 'Mushrooms and immunity', Journal of Autoimmunity, 117, pp. 102576. doi:10.1016/j.jaut.2020.102576 Meta-analysis / review
https://doi.org/10.1016/j.jaut.2020.102576 - Toros, G., El-Ramady, H., Prokisch, J., Velasco, F. and others (2023) 'Modulation of the Gut Microbiota with Prebiotics and Antimicrobial Agents from Pleurotus ostreatus Mushroom', Foods, 12(10), pp. 2010. doi:10.3390/foods12102010 Preclinical
https://doi.org/10.3390/foods12102010 - Mishra, V., Tomar, S., Yadav, P. and Singh, M.P (2021) 'Promising anticancer activity of polysaccharides and other macromolecules derived from oyster mushroom (Pleurotus sp.): An updated review', International Journal of Biological Macromolecules, 182, pp. 1628-1637. doi:10.1016/j.ijbiomac.2021.05.102 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2021.05.102 - Gu, Y.H. and Sivam, G (2006) 'Cytotoxic effect of oyster mushroom Pleurotus ostreatus on human androgen-independent prostate cancer PC-3 cells', Journal of Medicinal Food, 9(2), pp. 196-204. doi:10.1089/jmf.2006.9.196 Preclinical
https://doi.org/10.1089/jmf.2006.9.196 - Sharma, A., Sharma, A. and Tripathi, A (2021) 'Biological activities of Pleurotus spp. polysaccharides: A review', Journal of Food Biochemistry, 45(6), pp. e13748. doi:10.1111/jfbc.13748 Meta-analysis / review
https://doi.org/10.1111/jfbc.13748 - Krupodorova, T., Barshteyn, V., Tsygankova, V., Sevindik, M. and others (2024) 'Strain-specific features of Pleurotus ostreatus growth in vitro and some of its biological activities', BMC Biotechnology, 24(1), pp. 9. doi:10.1186/s12896-024-00834-9 Preclinical
https://doi.org/10.1186/s12896-024-00834-9 - Perez-Bassart, Z., Bauerl, C., Fabra, M.J., Martinez-Abad, A. and others (2023) 'Composition, structural properties and immunomodulatory activity of several aqueous Pleurotus beta-glucan-rich extracts', International Journal of Biological Macromolecules, 253(Pt 6), pp. 127255. doi:10.1016/j.ijbiomac.2023.127255 Preclinical
https://doi.org/10.1016/j.ijbiomac.2023.127255 - Dos Santos, J.F., de Oliveira, N.M.T., da Silva Milhorini, S., Rutckeviski, R. and others (2025) 'The use of Pleurotus ostreatus by-products for the preparation of a gel-like polysaccharide with bioactive properties', International Journal of Biological Macromolecules, 301, pp. 140236. doi:10.1016/j.ijbiomac.2025.140236 Preclinical
https://doi.org/10.1016/j.ijbiomac.2025.140236 - Huang, X. and Nie, S (2015) 'The structure of mushroom polysaccharides and their beneficial role in health', Food & Function, 6(10), pp. 3205-3217. doi:10.1039/c5fo00678c Meta-analysis / review
https://doi.org/10.1039/c5fo00678c - Drezek, J. and Mozejko-Ciesielska, J (2025) 'Production of beta-Glucans by Pleurotus ostreatus: Cultivation and Genetic Background', International Journal of Molecular Sciences, 26(19), pp. 9703. doi:10.3390/ijms26199703 Preclinical
https://doi.org/10.3390/ijms26199703 - Spacek, J., Vocka, M., Zavadova, E., Konopasek, B. and Petruzelka, L (2021) 'Immunomodulation with beta-glucan from Pleurotus ostreatus in patients with endocrine-dependent breast cancer', Immunotherapy, 14(1), pp. 31-40. doi:10.2217/imt-2021-0069 Clinical study
https://doi.org/10.2217/imt-2021-0069 - Majtan, J (2012) 'Pleuran (beta-glucan from Pleurotus ostreatus): an effective nutritional supplement against upper respiratory tract infections?', Medicine and Sport Science, 59, pp. 57-61. doi:10.1159/000341967 Clinical study
https://doi.org/10.1159/000341967 - Gariboldi, M.B., Marras, E., Ferrario, N., Vivona, V., Prini, P., Vignati, F. and Perletti, G (2023) 'Anti-Cancer Potential of Edible/Medicinal Mushrooms in Breast Cancer', International Journal of Molecular Sciences, 24(12), pp. 10120. doi:10.3390/ijms241210120 Preclinical
https://doi.org/10.3390/ijms241210120 - Gonmori, K. and Yokoyama, K (2009) 'Acute encephalopathy caused by cyanogenic fungi in 2004, and magic mushroom regulation in Japan', Chudoku Kenkyu, 22(1), pp. 61-9. Available at: https://pubmed.ncbi.nlm.nih.gov/19344063/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/19344063/ - Wasser, S.P (2011) 'Current findings, future trends, and unsolved problems in studies of medicinal mushrooms', 89(5), pp. 1323--1332. doi:10.1007/s00253-010-3067-4 Randomized trial
https://doi.org/10.1007/s00253-010-3067-4 - Guillamon, E. et al (2010) 'Edible mushrooms: role in the prevention of cardiovascular diseases', 81(7), pp. 715--723. doi:10.1016/j.fitote.2010.06.005 Clinical study
https://doi.org/10.1016/j.fitote.2010.06.005 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Yamamoto, N. and Suzuki, T. and Kobayashi, M. and others (2014) 'A-WINGS: an integrated genome database for Pleurocybella porrigens (angel's wing oyster mushroom, Sugihiratake)', BMC Research Notes, 7, pp. 866. doi:10.1186/1756-0500-7-866 Preclinical
https://doi.org/10.1186/1756-0500-7-866 - Mushroom Appreciation (2024) 'Angel wings vs oyster mushrooms: identification and controversy'. Available at: https://www.mushroom-appreciation.com/angel-wings-identification.html Traditional / reference
https://www.mushroom-appreciation.com/angel-wings-identification.html - Sugano, Y. and Sakata, K. and Nakamura, K. and others (2017) 'Rapid identification method of Omphalotus japonicus by PCR-RFLP', Shokuhin Eiseigaku Zasshi, 58(3), pp. 113-123. doi:10.3358/shokueishi.58.113 Preclinical
https://doi.org/10.3358/shokueishi.58.113 - Kasahara, Y (2013) 'Clinical toxicology of mushroom poisoning: Omphalotus guepiniformis', Chudoku Kenkyu, 26(3), pp. 215-8. Available at: https://pubmed.ncbi.nlm.nih.gov/24224384/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/24224384/ - Mushroom Appreciation (2024) 'The jack o'lantern mushroom (Omphalotus olearius)'. Available at: https://www.mushroom-appreciation.com/omphalotus-olearius.html Traditional / reference
https://www.mushroom-appreciation.com/omphalotus-olearius.html
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.